Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient-Reference-Cited by-同舟云学术

Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient

Published:2020-07-20 Issue:11 Volume:55 Page:2990-2994
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Gainey Andrew B.¹^ORCID,Burch Anna‐Kathryn²,Brownstein Michael J.³,Brown David E.⁴,Fackler Joseph³,Horne Bri'Anna³,Biswas Biswajit⁵,Bivens Brittany N.⁵,Malagon Francisco⁵,Daniels Robert¹

Affiliation:

1. Department of Pharmacy, Division of Pediatric Infectious Diseases Prisma Health Children's Hospital ‐ Midlands Columbia South Carolina

2. Department of Pediatrics, Division of Pediatric Infectious Diseases Prisma Health Children's Hospital ‐ Midlands Columbia South Carolina

3. Adaptive Phage Therapeutics Gaithersburg Maryland

4. Department of Pediatrics, Division of Pediatric Pulmonology Prisma Health Children's Hospital ‐ Midlands Columbia South Carolina

5. Department of Genomics & Bioinformatics Biological Defense Research Directorate, Naval Medical Research Center Frederick Maryland

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.24945

Reference13 articles.

1. Cefiderocol for treatment of complicated urinary tract infections

2. Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

3. In VivoPharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection Models

4. TsujiM NakamuraR KohiraN ItoA SatoT YamanoYS‐649266 a novel siderophore cephalosporin: in vitro combination effect of S‐649266 and other antibiotics against Gram‐negative bacteria. Presentation presented atthe:2016; ECCMID Amsterdam The Netherlands.

5. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study;Pediatric Infectious Disease Journal;2024-09-04

2. Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus;Annals of Clinical Microbiology and Antimicrobials;2024-08-22

3. Antimicrobial resistance: use of phage therapy in the management of resistant infections;Molecular Biology Reports;2024-08-21

4. Phage Therapy: An Alternative Approach to Combating Multidrug-Resistant Bacterial Infections in Cystic Fibrosis;International Journal of Molecular Sciences;2024-07-30

5. Micro-plaque assays: A high-throughput method to detect, isolate, and characterize bacteriophages;2024-06-20